Tesla Gains 4% on Capital-Infusion Announcement

Tesla Gains 4% on Capital-Infusion Announcement

Brian Mackey, deputy director of research at Adviser Investments, has the market analysis for Thursday, May 2. Major U.S. stock indexes declined slightly for the second consecutive day. Both the Dow Jones Industrial Average and S&P 500 fell 0.5% and the NASDAQ Composite declined 0.2% due, in part, to trade-negotiation uncertainty. Although both the U.S. and China have expressed optimism for a final agreement, there are concerns it will address neither cybersecurity concerns nor Chinese industrial subsidies. Meanwhile, Tesla made headlines with its $2 billion capital infusion plan, $10 million of which will be funded by Co-founder and CEO Elon Musk. Tesla’s stock surged 4% on the news, with shareholders welcoming the announcement following Tesla’s first-quarter earnings miss.


Recent Videos

View All Videos

Lowell on CNBC: Nervous Markets Call for a Balanced, Disciplined Investment Approach

Lowell on CNBC: Perspective on Dow’s 800-Point Drop

Stock Indexes Decline 3% but Long-Term Prospects Remain Strong

Lowell on CNBC: Current Market Offers Long-Term Opportunity

85 Wells Avenue, Suite 109 Newton, MA, 02459

info@adviserinvestments.com 1.800.492.6868

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.